Ptprg and BCR/ABL1 Expression In CML Patients At Diagnosis and Upon TKI Treatment: Preliminary Results

被引：0
|
作者：
Monne, Maria
Piras, Giovanna
Vezzalini, Marzia
Bras, Antonella
Murineddu, Marco
Yassin, Mohamed A.
Al-Dewik, Nader I.
Latte, Giancarlo
Sorio, Claudio
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.5163.5163
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5163
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia
    Gupta, Manu
    Milani, Lili
    Hermansson, Monica
    Simonsson, Bengt
    Markevarn, Berit
    Syvdnen, Ann Christine
    Barbany, Gisela
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 366 (03) : 848 - 851
  • [42] BCR-ABL transcript levels and BCR-ABL/BCR transcript ratios in CML patients with good or bad response to treatment.
    Moravcová, J
    Regner, J
    Brezinová, J
    Klamová, H
    BLOOD, 2001, 98 (11) : 264B - 264B
  • [43] Association of BCR-ABL mutation testing in patients with CML with likelihood of improvement in subsequent BCR-ABL test results.
    Smyth, Carol
    Bhan, Jason M.
    Dhaliwal, Ajitpal Singh
    Sorokina, Tatiana
    Parikh, Niyati
    Levitz, Jason S.
    Radich, Jerald P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
    Poonam, Jain P.
    Mayur, Parihar
    Rayaz, Ahmed
    Aby, Abraham
    Auro, Vishwabandya
    Biju, George
    Vikram, Mathews
    Alok, Srivastava
    Vivi, Srivastava M.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 347 - 351
  • [45] BCR-ABL1INS35 Is Not Uncommon in CML Patients and Is Related to Resistance and Sensitivity to Inhibitors in CML Treatment - Response
    Lee, Tai-Sung
    Ma, Wanlong
    Zhang, Xi
    Albitar, Maher
    Giles, Francis
    Cortes, Jorge
    Kantarjian, Hagop
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (03) : 773 - 773
  • [46] BCR-ABL, BCR AND ABL EXPRESSION IN PH-POSITIVE CFU-GM COLONIES FROM CML PATIENTS - RARITY OF BCR-ABL NEGATIVE COLONIES
    DIAMOND, J
    GOLDMAN, J
    MELO, JV
    BLOOD, 1994, 84 (10) : A138 - A138
  • [47] GENEXPERT BCR-ABL1/ABL1 MONITOR TEST (IS) FOR ROUTINE MONITORING OF CHRONIC MYELOID LEUKEMIA PATIENTS
    Balatzenko, G.
    Hrischev, V.
    Lilova, A.
    Guenova, M.
    HAEMATOLOGICA, 2014, 99 : 78 - 78
  • [48] Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population
    Kuan, Jew Win
    Su, Anselm Ting
    Sim, Sai-Peng
    Tay, Siow Phing
    BMC CANCER, 2024, 24 (01)
  • [49] Does Detection of <20% Lymphoblasts in Patients with CML Herald Imminent Blast Crisis? a Study from BCR::ABL1 Pathology Group
    Gong, Zimu
    Qiu, Lianqun
    DiGiuseppe, Joseph
    Xue, Mengxing
    Soma, Lorinda
    Wang, Wei
    Zhou, Yi
    Shen, Qi
    Zhu, Mingqing
    Naik, Anisha
    Chen, Weina
    Wang, Wei J.
    Wang, Sa A.
    Medeiros, L. Jeffrey
    Jabbour, Elias
    Kantarjian, Hagop M.
    Cortes, Jorge
    Radich, Jerald P.
    Khoury, Joseph D.
    Hochhaus, Andreas
    Apperley, Jane F.
    Chen, Suning
    Naresh, Kikkeri N.
    Hu, Shimin
    BLOOD, 2023, 142
  • [50] WT1 AND PRAME EXPRESSION IN CML PATIENTS PREDICT IMATINIB RESISTANCE AND BCR/ABL GENE MUTATIONS
    Misyurin, A.
    Aksenova, E.
    Krutov, A.
    Soldatova, I.
    Kesaeva, L.
    Turkina, A.
    Khoroshko, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 335 - 335
12345